Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm Metastasis × Reverse Transcriptase Polymerase Chain Reaction × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Rectal Neoplasms 2 Lung Neoplasms 2 Leukemia 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Multiple Myeloma 1 Liposarcoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1

Interventions

Gemcitabine 33 Paclitaxel 27 Capecitabine 27 pembrolizumab 26 Bevacizumab 26 Nivolumab 25 Fluorouracil 25 Docetaxel 24 Oxaliplatin 23 Cyclophosphamide 21 Leucovorin 20 Cisplatin 20 aldesleukin 17 Carboplatin 17 Radiosurgery 16 Irinotecan 15 Interleukin-2 15 fludarabine phosphate 14 fludarabine 14 Cetuximab 14 Prednisone 13 Ipilimumab 13 Trastuzumab 12 Pemetrexed 12 Fulvestrant 12 Everolimus 12 Magnetic Resonance Spectroscopy 11 Panitumumab 10 130-nm albumin-bound paclitaxel 10 abemaciclib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡